World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
41
Citations
6135
World Ranking
7899
National Ranking
3397

Overview

Caryl E. Sortwell is affiliated with Michigan State University in the United States. Their research focuses primarily on the fields of Medicine and Neuroscience, with specific attention to Neurology and Cellular and Molecular Neuroscience. Other areas of study include Molecular Biology, Physiology, and Cognitive Neuroscience.

The main topics in Sortwell's work involve Parkinson's Disease mechanisms and treatments, neurological disorders and treatments, nerve injury and regeneration, botulinum toxin and related neurological disorders, neuroscience and neuropharmacology research, Alzheimer's disease research and treatments, as well as nuclear receptors and signaling.

Recent publications by Sortwell include:

  • α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease, 2021, JCI Insight
  • Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits, 2020, Neurobiology of Disease
  • Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor, 2021, npj Parkinson s Disease
  • Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS, 2021, Journal of Neuroscience
  • Next-Generation Diamond Electrodes for Neurochemical Sensing: Challenges and Opportunities, 2021, Micromachines

Sortwell frequently publishes in prominent venues related to neuroscience and neurological diseases, including:

  • Neurobiology of Disease
  • npj Parkinson s Disease
  • Journal of Visualized Experiments
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Neuroscience

Collaborative work is common in Sortwell's career, with frequent coauthors including:

  • Joseph R. Patterson
  • Christopher J. Kemp
  • Kathy Steece-Collier
  • Kelvin C. Luk
  • Anna C. Stoll

Best Publications

  • Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration

    Katrina L. Paumier;Kelvin C. Luk;Fredric P. Manfredsson;Nicholas M. Kanaan

  • Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents.

    Nicole K. Polinski;Laura A. Volpicelli-Daley;Caryl E. Sortwell;Kelvin C. Luk

  • Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons

    Susan O McGuire;Zao Dung Ling;Jack W Lipton;Caryl E Sortwell

  • A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.

    P.M. Carvey;Z.D. Ling;C.E. Sortwell;M.R. Pitzer

  • Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.

    Megan F Duffy;Timothy J Collier;Joseph R Patterson;Christopher J Kemp

  • TRANSFER OF HOST-DERIVED ALPHA SYNUCLEIN TO GRAFTED DOPAMINERGIC NEURONS IN RAT

    Jeffrey H. Kordower;Hemraj B. Dodiya;Adam M. Kordower;Brian Terpstra

  • Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism

    Timothy J. Collier;Jack Lipton;Brian F. Daley;Stephane Palfi

  • Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival.

    Caryl E. Sortwell;Mark R. Pitzer;Timothy J. Collier

  • Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys.

    Jeffrey H. Kordower;Nicholas M. Kanaan;Yaping Chu;Rangasamy Suresh Babu

  • Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss

    A.L. Spieles-Engemann;M.M. Behbehani;T.J. Collier;S.L. Wohlgenant

  • Subthalamic Nucleus Stimulation Increases Brain Derived Neurotrophic Factor in the Nigrostriatal System and Primary Motor Cortex

    Anne L. Spieles-Engemann;Kathy Steece-Collier;Michael M. Behbehani;Timothy J. Collier

  • α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease.

    Tracy A. Cole;Hien Zhao;Timothy J. Collier;Ivette Sandoval

  • Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats

    Eleonora Maries;Jeffrey H. Kordower;Yaping Chu;Timothy J. Collier

  • Therapeutic potential of nerve growth factors in Parkinson's disease.

    Timothy J. Collier;Caryl E. Sortwell

  • Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation.

    Timothy J. Collier;Caryl E. Sortwell;Brian F. Daley

  • Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity.

    Matthew J. Benskey;Rhyomi C. Sellnow;Ivette M. Sandoval;Ivette M. Sandoval;Caryl E. Sortwell;Caryl E. Sortwell

  • Morphological and Behavioral Impact of AAV2/5-Mediated Overexpression of Human Wildtype Alpha-Synuclein in the Rat Nigrostriatal System

    Sara E. Gombash;Sara E. Gombash;Fredric P. Manfredsson;Christopher J. Kemp;Nathan C. Kuhn

  • Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.

    Joseph R. Patterson;Megan F. Duffy;Christopher J. Kemp;Jacob W. Howe

  • Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease

    Deanna M. Marchionini;Elin Lehrmann;Yaping Chu;Bin He

  • Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats.

    Katherine E. Soderstrom;Jennifer A. O’Malley;Nathan D. Levine;Caryl E. Sortwell

  • Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells

    Mark R Pitzer;Caryl E Sortwell;Brian F Daley;Susan O McGuire

  • Oligodendrocyte-type 2 astrocyte-derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death.

    Caryl E. Sortwell;Brian F. Daley;Mark R. Pitzer;Susan O. McGuire

Frequent Co-Authors

Kathy Steece-Collier
Kathy Steece-Collier Michigan State University
Jack W. Lipton
Jack W. Lipton Michigan State University
Timothy J. Collier
Timothy J. Collier Michigan State University
Nicholas M. Kanaan
Nicholas M. Kanaan Michigan State University
Jeffrey H. Kordower
Jeffrey H. Kordower Arizona State University
Yaping Chu
Yaping Chu Rush University Medical Center
Scott E. Counts
Scott E. Counts Michigan State University
Sheila M. Fleming
Sheila M. Fleming University of Cincinnati
John R. Sladek
John R. Sladek University of Colorado Denver
Paul M. Carvey
Paul M. Carvey Rush University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Caryl E. Sortwell

Trending Scientists

Recently Published Articles